Image

Gastric Pathophysiology in Diabetes

Recruiting
18 - 70 years of age
Both
Phase N/A

Powered by AI

Overview

This is a comprehensive pathophysiological study assessing various gastric functions in patients with diabetes mellitus. The investigators aim to examine the stomach with various measurement devices to gain information about its different functions and malfunctions. After the initial measurements, the examinations will be repeated after a year in each patient. Changes in the measurement values will be examined and their relations to each other and to the overall health of the patients will be investigated.

For example it is hypothesised that diabetic patients also suffering from functional dyspepsia or gastroparesis will also show some changes in the function of the pyloric muscle.

Eligibility

Inclusion Criteria (diabetic group):

  • Diabetes mellitus type I or II, minimal duration of the disease 3 years, minimal duration of specific treatment (drugs, insulin) 2 years

Exclusion Criteria (diabetic group):

  • Diabetes mellitus type II being treated with a diet only
  • Severe acute decompensation of diabetes (uncontrolled diabetes) necessitating hospitalization
  • Concomitant treatment with more than one prokinetic agent
  • Active treatment with opioids or a history of treatment with opioids within 12 months before enrolment
  • Previous esophageal or major gastric surgery (e.g. esophageal myotomy, esophagectomy, antireflux surgery, Billroth I or II gastric resection, gastric pull-through, pyloromyotomy, pyloroplasty, gastric electrical stimulation)
  • Organic pyloric (or intestinal) obstruction (fibrotic stricture, etc.)
  • Severe coagulopathy
  • Esophageal or gastric varices and /or portal gastropathy
  • Advanced liver cirrhosis
  • Pregnancy or puerperium
  • Malignant or pre-malignant gastric diseases (dysplasia, gastric cancer, GIST): patients with a history of such disease after its cure are eligible for enrolment
  • The presence of a rumination syndrome or eating disorders (anorexia nervosa, bulimia). In case of doubts, a psychiatric examination will be performed.
  • Systemic connective tissue disorder
  • Inability to obtain informed consent
  • Any other condition, which in the opinion of the investigator would interfere with study requirements

Study details

Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Functional Dyspepsia

NCT06068114

Institute for Clinical and Experimental Medicine

24 May 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.